Biological Dynamics Appoints Industry Veteran Peter Wulff as Chief Financial Officer
/Biological Dynamics, Inc., a company developing and commercializing its proprietary ExoVerita™ platform for early disease detection and other applications, today announced Peter C. Wulff as Chief Financial Officer effective January 1, 2023.
Read More